Bicara Therapeutics Inc (NASDAQ:BCAX) traded at $15.84 at last check on current trade day and made an upward move of 14.58% on its previous day’s price.
Looking at the stock we see that its previous close was $13.82 with the day’s price range being $13.66 – $16.17. In terms of its 52-week price range, BCAX has a high of $28.09 and a low of $8.91. The company’s stock has gained about 14.75% over that past 30 days.
Bicara Therapeutics Inc has a market cap of $863.37 million and is expected to release its quarterly earnings report on 2025-Mar-26.
Looking further, we note the current price level is 31.68% off its SMA20 and 23.03% from its 50-day simple moving average. The RSI (14) is pointing at 68.70 while the volatility over the past week is 12.44% and jumps to 12.71% over the past one month. The average price target for the stock over the next 12 months is $48, with the estimates having a low of $48 and a high of $48. These price ends are -203.03% and -203.03% off the today’s price level respectively, although investors could be excited at the prospect of a -203.03% if the BCAX share price touches on the median price of $48.
Coming back to Bicara Therapeutics Inc (NASDAQ:BCAX), we note that the average 3-month trading volume was 477.78K, while that of the preceding 10-day period stands at 0.49 million. Current shares outstanding are 54.44 million.
The insiders hold 43.23% of the company’s shares while institutions hold 55.47%. The data shows that short shares as of 2025-03-31, stood at 5.05 million at a short ratio of 8.91. Shares short fall in March from the previous month at 5.61 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -9.10% down in year-to-date price movement.
